BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 4898982)

  • 1. Isolation and partial characterization of an immunogenic moiety obtained from Salmonella typhimurium.
    Venneman MR; Bigley NJ
    J Bacteriol; 1969 Oct; 100(1):140-8. PubMed ID: 4898982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribosomal vaccines. I. Immunogenicity of ribosomal fractions isolated from Salmonella typhimurium and Yersinia pestis.
    Johnson W
    Infect Immun; 1972 Jun; 5(6):947-52. PubMed ID: 4564407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ribosomal vaccines. II. Specificity of the immune response to ribosomal ribonucleic acid and protein isolated from Salmonella typhimurium.
    Johnson W
    Infect Immun; 1973 Sep; 8(3):395-400. PubMed ID: 4199718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of immunogenically active ribonucleic acid preparations of Salmonella typhimurium: molecular-sieve and anion-exchange chromatography.
    Venneman MR
    Infect Immun; 1972 Mar; 5(3):269-82. PubMed ID: 4564556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of ribosomal preparations from Neisseria gonorrhoeae.
    Cooper MD; Tewari RP; Bowser DV
    Infect Immun; 1980 Apr; 28(1):92-100. PubMed ID: 6769823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of trypsin and ribonuclease on the immunogenic activity of ribosomes and ribonucleic acid isolated from Mycobacterium tuberculosis.
    Youmans AS; Youmans GP
    J Bacteriol; 1966 Jun; 91(6):2146-54. PubMed ID: 4957610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenic dialyzable factor derived from a ribosomal fraction of Salmonella typhimurium. I. Preparation of the protective dialyzable factor from the ribosomal fraction by the freeze-thaw procedure.
    Kita E; Matsuura H; Masuda S; Tomihata S; Kashiba S
    Microbiol Immunol; 1983; 27(1):7-24. PubMed ID: 6346023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for an extrinsic immunogen in effective ribosomal vaccines from Salmonella typhimurium.
    Hoops P; Prather NE; Berry J; Ravel JM
    Infect Immun; 1976 Apr; 13(4):1184-92. PubMed ID: 776831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of protective cell surface proteins in ribosomal fractions from Salmonella typhimurium.
    Misfeldt ML; Johnson W
    Infect Immun; 1979 Jun; 24(3):808-16. PubMed ID: 381202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An attempt to localize the vaccinating power of Klebsiella pneumoniae ribosomal preparations using saccharose-gradient ultracentrifugation.
    Robert D; Bienvenu P; Lafont S; Jouanneteau B; Normier G; Dussourd D'Hinterland L; Fontanges R
    Microbiol Immunol; 1982; 26(10):941-50. PubMed ID: 6761558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of Ribonucleic Acid Preparations Obtained from Salmonella typhimurium.
    Venneman MR; Bigley NJ; Berry LJ
    Infect Immun; 1970 Jun; 1(6):574-82. PubMed ID: 16557778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of immunity to infection with Salmonella typhimurium in outbred mice. II. Isolation and immunogenicity of the protective non-O antigenic component from ribosomal vaccine.
    Kita E; Emoto M; Katsui N; Nishi K; Yasui K; Yasui K; Kashiba S
    Immunology; 1987 Oct; 62(2):235-40. PubMed ID: 2445665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired immunity against mouse typhoid: genetic restriction and comparative efficacy of ribosomal and conventional vaccines.
    Nickol AD; Bonventre PF
    J Med Microbiol; 1981 Nov; 14(4):419-33. PubMed ID: 7031251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum-mediated resistance induced with immunogenic preparations of Salmonella typhimurium.
    Venneman MR; Berry LJ
    Infect Immun; 1971 Oct; 4(4):374-80. PubMed ID: 4949497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of mice to injection of ribosomal fraction from group B Neisseria meningitidis.
    Thomas DW; Weiss E
    Infect Immun; 1972 Sep; 6(3):355-63. PubMed ID: 4629260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of highly immunogenic ribosomal fractions of Mycobacterium tuberculosis by use of sodium dodecyl sulfate.
    Youmans AS; Youmans GP
    J Bacteriol; 1966 Jun; 91(6):2139-45. PubMed ID: 4957609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for O antigens as the antigenic determinants in "ribosomal" vaccines prepared from Salmonella.
    Eisenstein TK
    Infect Immun; 1975 Aug; 12(2):364-77. PubMed ID: 51007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement of the conformational stability of a Salmonella ribosomal vaccine for its mouse protection.
    Kita E; Oku D; Nishikawa F; Emoto M; Yasui K; Kashiba S
    FEMS Microbiol Immunol; 1991 Aug; 3(4):229-39. PubMed ID: 1931135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribonuclease-sensitive ribosomal vaccine of Pseudomonas aeruginosa.
    Gonggrijp R; Mullers WJ; Lemmens PJ; van Boven CP
    Infect Immun; 1980 Jan; 27(1):204-10. PubMed ID: 6153637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of endotoxin contamination in ribiosomal vaccines prepared from Salmonella typhimurium.
    Misfeldt ML; Johnson W
    Infect Immun; 1977 Jul; 17(1):98-104. PubMed ID: 328399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.